Shockingly, the combined loss in market capitalization since late 2021 of Pfizer, Moderna, and BioNTech now exceeds the Gross Domestic Product (GDP) of Malaysia, South Africa, Denmark, the Philippines, Hong Song SAR, Columbia, Chile, the Czech Republic, Portugal, Finland, Greece, Hungary, Kuwait, Puerto Rico, Luxembourg, and most other countries. That […]
Report 63: In Q3 2022, Pfizer Wrote Off $450 Million of Expired or Expiring COVID-19-Related Inventory.
Despite generating over $100 billion in revenue in 2022, Pfizer’s stock has dropped precipitously. Pfizer’s revenue was relatively flat, hovering between $41 billion and $51 billion, from 2014 to 2020. Then, its mRNA COVID-19 “vaccine” was awarded Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) on December […]